Xbrane Biopharma AB (publ) (XBRANE.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Martin Amark | Chief Executive Officer | 3.37M | -- | 1980 |
| Mr. Siavash Bashiri | COO, Head of Biosimilars & Deputy CEO | 1.76M | -- | 1983 |
| Associate Prof. Jan-Willem De Gier | Co-Founder | -- | -- | -- |
| Dr. Samuel Wagner Ph.D. | Co-Founder & Member of Scientific Advisory Board | -- | -- | -- |
| Ms. Jane Benyamin | Interim CFO & Head of IR | -- | -- | 1979 |
| Dr. David Vikstrom | Chief Technology Officer | -- | -- | 1977 |
| Ms. Dina Jurman | Head of Clinical Affairs | -- | -- | 1982 |
| Mr. Anders Wallstrom | Head of Manufacturing & Supply Chain | -- | -- | 1976 |
| Mr. Håkan Yildirim | Head of Intellectual Property | -- | -- | -- |
Xbrane Biopharma AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 65
Description
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults; and XB003, a biosimilar candidate to certolizumab pegol for the treatment of rheumatoid arthritis, psoriasis, Crohn's disease and axial spondylitis. It also develops its pre-clinical phase products, such as Xdivane, a cell death 1 protein (PD1) inhibitor nivolumab biosimilar, indicated for melanoma, lung cancer, kidney cell cancer, head and neck cancer, and bladder and urinary tract cancer; Xdarzane, a daratumumab biosimilar candidate, indicated for multiple melanoma; and BIIB801, a certolizumab pegol biosimilar candidate, indicated for the treatment of rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis. The company was incorporated in 2008 and is headquartered in Solna, Sweden.
Corporate Governance
Upcoming Events
May 8, 2025 at 6:00 AM UTC
Xbrane Biopharma AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available